Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhoutie Pharmaceutical, officially known as Jiangsu Zhoutie Pharmaceutical Co., Ltd., is a Chinese pharmaceutical company specializing in the production of active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in the 1970s and based in Yixing, Jiangsu Province, the company has established itself as a significant manufacturer of anti-diabetic medications, including Metformin Hydrochloride and Gliclazide. Zhoutie Pharmaceutical operates large-scale manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards, supplying both domestic and international markets. The company's business model focuses on the mass production of essential generic medicines and chemical intermediates for the healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhou Tie.